131 related articles for article (PubMed ID: 37330122)
21. Universal Repeat Screening for Human Immunodeficiency Virus in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis.
Hawkinson LF; Chaiken SR; Doshi U; Wallace J; Caughey AB
Obstet Gynecol; 2023 Mar; 141(3):535-543. PubMed ID: 36800852
[TBL] [Abstract][Full Text] [Related]
22. Eviction as a social determinant of pregnancy health: County-level eviction rates and adverse birth outcomes in the United States.
Harville EW; Wallace ME; Theall KP
Health Soc Care Community; 2022 Nov; 30(6):e5579-e5587. PubMed ID: 36065610
[TBL] [Abstract][Full Text] [Related]
23. Obstetric management for stillbirth complicated by a prior cesarean delivery: a cost-effectiveness analysis.
Powell JM; Hersh AR; Greiner KS; Frank ZC; Pilliod RA; Caughey AB
J Matern Fetal Neonatal Med; 2022 Oct; 35(19):3684-3693. PubMed ID: 33103519
[TBL] [Abstract][Full Text] [Related]
24. Association of Eviction With Adverse Birth Outcomes Among Women in Georgia, 2000 to 2016.
Himmelstein G; Desmond M
JAMA Pediatr; 2021 May; 175(5):494-500. PubMed ID: 33646291
[TBL] [Abstract][Full Text] [Related]
25. First trimester fasting plasma glucose screen in advanced maternal age women: a cost-effectiveness analysis.
Waites BT; Walker AR; Skeith AA; Caughey AB
J Matern Fetal Neonatal Med; 2022 Nov; 35(21):4123-4129. PubMed ID: 33179564
[TBL] [Abstract][Full Text] [Related]
26. Universal Tetanus-Diphtheria-Pertussis Vaccination During Pregnancy: A Cost-Effectiveness Analysis.
Egan RC; Chaiken SR; Derrah K; Doshi U; Hersh A; Packer CH; Caughey AB
Obstet Gynecol; 2023 Apr; 141(4):837-844. PubMed ID: 36897561
[TBL] [Abstract][Full Text] [Related]
27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
28. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling.
Honest H; Forbes CA; Durée KH; Norman G; Duffy SB; Tsourapas A; Roberts TE; Barton PM; Jowett SM; Hyde CJ; Khan KS
Health Technol Assess; 2009 Sep; 13(43):1-627. PubMed ID: 19796569
[TBL] [Abstract][Full Text] [Related]
29. The Cost-Effectiveness of Professional Doula Care for a Woman's First Two Births: A Decision Analysis Model.
Greiner KS; Hersh AR; Hersh SR; Remer JM; Gallagher AC; Caughey AB; Tilden EL
J Midwifery Womens Health; 2019 Jul; 64(4):410-420. PubMed ID: 31034756
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth.
Einerson BD; Grobman WA; Miller ES
Am J Obstet Gynecol; 2016 Jul; 215(1):100.e1-7. PubMed ID: 26880732
[TBL] [Abstract][Full Text] [Related]
31. Universal cervical length screening with a cervicometer to prevent preterm birth <34 weeks: a decision and economic analysis.
McCurdy RJ; Baxter JK
J Matern Fetal Neonatal Med; 2020 Nov; 33(21):3670-3679. PubMed ID: 30760059
[No Abstract] [Full Text] [Related]
32. Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis.
Werner EF; Han CS; Pettker CM; Buhimschi CS; Copel JA; Funai EF; Thung SF
Ultrasound Obstet Gynecol; 2011 Jul; 38(1):32-7. PubMed ID: 21157771
[TBL] [Abstract][Full Text] [Related]
33. Timing of active phase labor arrest diagnosis in nulliparous women: a cost-effectiveness analysis.
Schmidt EM; Hersh AR; Tuuli M; Cahill AG; Caughey AB
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6124-6131. PubMed ID: 33818244
[TBL] [Abstract][Full Text] [Related]
34. Herpes Simplex Virus Serotyping in Pregnant Women With a History of Genital Herpes and an Outbreak in the Third Trimester of Pregnancy: A Cost-Effectiveness Analysis.
Chatroux IC; Hersh AR; Caughey AB
Obstet Gynecol; 2021 Jan; 137(1):63-71. PubMed ID: 33278294
[TBL] [Abstract][Full Text] [Related]
35. Cost-Effectiveness of Continuous Support From a Layperson During a Woman's First Two Births.
Greiner KS; Hersh AR; Hersh SR; Gallagher AC; Caughey AB; Tilden EL
J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):538-551. PubMed ID: 31325414
[TBL] [Abstract][Full Text] [Related]
36. Effect of covering perinatal health-care costs on neonatal outcomes in Switzerland: a quasi-experimental population-based study.
Epure AM; Courtin E; Wanner P; Chiolero A; Cullati S; Carmeli C
Lancet Public Health; 2023 Mar; 8(3):e194-e202. PubMed ID: 36841560
[TBL] [Abstract][Full Text] [Related]
37. Considering Criteria for Active Phase Labor Management of Nulliparous Women: A Cost-Effectiveness Analysis.
Schmidt EM; Hersh AR; Tuuli M; Cahill AG; Caughey AB
Am J Perinatol; 2023 Jan; 40(1):99-105. PubMed ID: 33940649
[TBL] [Abstract][Full Text] [Related]
38. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
Avram CM; Greiner KS; Tilden E; Caughey AB
Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
[TBL] [Abstract][Full Text] [Related]
39. State Perinatal Quality Collaborative for Reducing Severe Maternal Morbidity From Hemorrhage: A Cost-Effectiveness Analysis.
Wiesehan EC; Keesara SR; Krissberg JR; Main EK; Goldhaber-Fiebert JD
Obstet Gynecol; 2023 Feb; 141(2):387-394. PubMed ID: 36649352
[TBL] [Abstract][Full Text] [Related]
40. Cost Effectiveness of Neonatal Resuscitation at 22 Weeks of Gestation.
Yieh L; Dukhovny D; Zhou CG; Gievers L; Caughey AB
Obstet Gynecol; 2019 Jun; 133(6):1199-1207. PubMed ID: 31135735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
